The
second most common reason for the recall of pharmaceutical products is fungal
contamination. To assess current trends and to evaluate risks, Tim Sandle has
written an article for the European Pharmaceutical Review.
Most
reports relating to the contamination of pharmaceutical products centre on
bacterial contamination rather than fungi. The reasons for this may relate to
few 'microbiology' laboratories in pharmaceutical organisations having trained
mycologists; to an underestimation of the association between fungi and product
contamination incidents; and due to a lack of appreciation of the risks that
fungi can pose to cleanrooms and controlled environments. This article
considers some of these issues and, in doing so, argues that the contamination
risk posed by fungi to pharmaceutical products is greater than the level of
industrial and academic interest would suggest.
The
reference for the article is:
Sandle,
T. (2014) Fungal contamination of pharmaceutical products: the growing menace, European Pharmaceutical Review, 19 (1):
68-71
Posted by Tim Sandle
No comments:
Post a Comment
Pharmaceutical Microbiology Resources